Intended for healthcare professionals

Letters

Early trials of angiogenic factors have not targeted patients most at risk of ocular disease

BMJ 1999; 319 doi: https://doi.org/10.1136/bmj.319.7210.643c (Published 04 September 1999) Cite this as: BMJ 1999;319:643